What is the protocol for preparing a dopamine drip for an infant?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Dopamine Drip Preparation for Infants

The recommended method for preparing a dopamine drip for an infant is to use the "rule of 6": multiply 0.6 × body weight (kg) to determine the number of milligrams of dopamine to dilute in 100 mL of saline; then 1 mL/h delivers 0.1 mcg/kg/min. 1

Standard Preparation Method

  • Use the "rule of 6" formula: 0.6 × weight (kg) = mg of dopamine to add to 100 mL of saline 1
  • For example, for a 5 kg infant: 0.6 × 5 = 3 mg dopamine in 100 mL saline
  • This standardized concentration allows for precise dosing where 1 mL/hr = 0.1 mcg/kg/min 1
  • Alternatively, prepare a standard solution of 400 mg dopamine in 500 mL D5W for larger infants or when higher concentrations are needed 1, 2

Administration Guidelines

  • Administer only via infusion pump, preferably a volumetric pump - never by gravity drip 2
  • Infuse into a large vein whenever possible (antecubital fossa preferred over dorsum of hand or ankle) to prevent infiltration 2
  • Typical dosing range for infants: 2-20 mcg/kg/min, titrated to desired effect 1, 2
  • Dosing effects are concentration-dependent 1:
    • Low doses (<5 mcg/kg/min): Primarily dopaminergic effects (renal and mesenteric vasodilation)
    • Intermediate doses (5-10 mcg/kg/min): β-adrenergic effects (increased cardiac contractility)
    • Higher doses (>10 mcg/kg/min): α-adrenergic effects (peripheral vasoconstriction)

Critical Safety Considerations

  • Do NOT administer if solution is darker than slightly yellow or discolored in any way 2
  • Do NOT add sodium bicarbonate or other alkalinizing substances as dopamine is inactivated in alkaline solution 2
  • Cover the bottle, burette, or syringe pump with protective foil to avoid breakdown by light (IV tubing does not need protection) 3
  • Monitor blood pressure continuously, preferably with an arterial line during administration 3
  • Exercise extreme caution to avoid accidental flushing/bolus injection of the IV line 3
  • Watch for extravasation which can cause severe skin injury; phentolamine (0.1-0.2 mg/kg) injected intradermally at extravasation site may counteract dermal vasoconstriction 3

Monitoring During Infusion

  • Continuous monitoring of vital signs including blood pressure, heart rate, and ECG is essential 1
  • Assess peripheral perfusion regularly 1
  • Monitor urine output - diminishing urine flow may indicate need to reduce dosage 2
  • Watch for tachycardia or development of new dysrhythmias which may necessitate decreasing or temporarily suspending the dosage 2, 4

Special Considerations for Neonates

  • Neonates may have diminished inotropic response compared to older children due to maturational differences in norepinephrine stores 4
  • Clearance varies widely in the pediatric population - elimination half-life is approximately 2 minutes in full-term neonates but may be as long as 4-5 minutes in preterm infants 4
  • Preterm infants may require higher initial doses (≥10 mcg/kg/min) to achieve blood pressure response 5
  • Preterm infants demonstrate decreased metabolic clearance rate of dopamine, which should be considered when determining dosing 6

References

Guideline

Dopamine Administration in Pediatric Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.